-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Aptose Biosciences Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2022 to Q4 2024.
- Aptose Biosciences Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 699K shares, a 210% increase year-over-year.
- Aptose Biosciences Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 699K shares, a 210% increase from 2023.
- Aptose Biosciences Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 225K shares, a 96.3% decline from 2022.
- Aptose Biosciences Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6.15M shares, a 6805% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)